Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome

1 Jan 2016

Abstract excerpt

Recombinant adeno-associated viral vectors (rAAV) are probably the most powerful tools for in vivo gene delivery. Encouraging preclinical data have been followed by successful gene therapy clinical trials including Leber's congenital amaurosis type 2 (refs. 1–3), hemophilia B,4,5 and recently choroideremia.6 These results together with the market authorization of Glybera, an AAV-based product for the treatment of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26942207
DOI: 10.1038/mtm.2015.49

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcomePMID 26942207Read ↗

Overcoming Bottlenecks in AAV Manufacturing for Gene TherapySemantic proximity Read ↗

Viral Vectors in Gene Replacement TherapySemantic proximity Read ↗

Progress and challenges in viral vector manufacturingSemantic proximity Read ↗

Manufacturing of recombinant adeno-associated viral vectors for clinical trialsSemantic proximity Read ↗

AAVR: A Multi-Serotype Receptor for AAVSemantic proximity Read ↗

Considerations for Preclinical Safety Assessment of Adeno-Associated Virus Gene Therapy ProductsSemantic proximity Read ↗

Production of Recombinant Adeno-Associated Virus VectorsSemantic proximity Read ↗

Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?Semantic proximity Read ↗

Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera<sup>®</sup>)Semantic proximity Read ↗

Molecular design for recombinant adeno-associated virus (rAAV) vector productionSemantic proximity Read ↗

Viral and non-viral vectors in gene therapy: current state and clinical perspectivesSemantic proximity Read ↗

Viral vector manufacturing: how to address current and future demands?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.